Lycera Announces Research Collaboration with Merck
Lycera Corporation, a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat...
Shire Strengthens Specialty Pharmaceuticals Team with Senior R&D Appointments
Shire plc, the global specialty biopharmaceutical company, today announced the appointment of two senior Research...
Maximising Drug Discovery Research
Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB "Drug discovery scientists...
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. announced that King has resubmitted a New Drug...
King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX Tablets
King Pharmaceuticals®, Inc. and Acura Pharmaceuticals, Inc. announced that King has submitted a New Drug...
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
Pfizer Inc. announced that a significantly higher proportion of patients with newly diagnosed chronic myeloid...
Bottlenecks in vaccine development: Eliminate from the beginning
Promising vaccine candidates, rising global demand and preparations for the next pandemic influenza have...
New technique to speed up drug development
Scientists working at the European Molecular Biology Laboratory in Grenoble, France have developed a new...
Optimer Pharmaceuticals Completes New Drug Application for Fidaxomicin
Optimer Pharmaceuticals, Inc.announced that it has completed the submission of its New Drug Application (NDA)...
New data show potential for Novartis Meningitis B vaccine
New data demonstrated that antibodies induced by Novartis Vaccines investigational, four component, Meningococcal Serogroup B...
